Similar articles

• National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

  Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, Edwards KM, Griffin MR. Grijalva CG, et al. Pediatrics. 2006 Sep;118(3):865-73. doi: 10.1542/peds.2006-0492. Pediatrics. 2006. PMID: 16950975
• Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.

  Garbutt J, Rosenbloom I, Wu J, Storch GA. Garbutt J, et al. Pediatrics. 2006 Jun;117(6):e1087-94. doi: 10.1542/peds.2005-2651. Pediatrics. 2006. PMID: 16740811
• Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine.

  Poehling KA, Szilagyi PG, Grijalva CG, Martin SW, LaFleur B, Mitchel E, Barth RD, Nuorti JP, Griffin MR. Poehling KA, et al. Pediatrics. 2007 Apr;119(4):707-15. doi: 10.1542/peds.2006-2138. Pediatrics. 2007. PMID: 17403841
• Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine.

  Brunton S. Brunton S. Clin Ther. 2006 Jan;28(1):118-23. doi: 10.1016/j.clinthera.2006.01.011. Clin Ther. 2006. PMID: 16490585 Review.
• Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal conjugate vaccine.

  Benninger MS. Benninger MS. Otolaryngol Head Neck Surg. 2008 Mar;138(3):274-8. doi: 10.1016/j.otohns.2007.11.011. Otolaryngol Head Neck Surg. 2008. PMID: 18312870 Review.